Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript

Question-and-Answer SessionThomas SchuetzCEO & Vice Chairman Sure. Compass, we're based in Boston. We're a monoclonal antibody discovery and development company in oncology. We currently have 3 drugs in the clinic and a fourth drug about to enter the clinic. So 2026, to answer your question specifically, is going to be an incredibly eventful year for us. We -- for our lead program, Tovecimig, a DLL4xVEGF-A bispecific antibody. We have a readout on the secondary endpoints of progression-free survival and ove ...